Interproximal access efficacy of three manual toothbrushes with extended, x-angled or flat multitufted bristles.

PURPOSE: This laboratory research study was conducted to evaluate three manual toothbrushes for their ability to remove artificial plaque from interproximal sites. MATERIALS AND METHODS: Interproximal access efficacy (IAE) was evaluated using a pressure-sensitive artificial plaque substrate placed around simulated anterior and posterior teeth with horizontal and vertical brushing motions. Efficacy was determined as the maximum width of artificial plaque removed from around the teeth. Testing was conducted on three manual toothbrushes with different bristle configurations coded as: Extended [Aquafresh Between Teeth (also marketed as Dr. Best Zwischenzahn)], X-angled (Oral-B CrossAction) and Flat multitufted (Oral-B Indicator). Twenty-four tests on each toothbrush design were conducted, and the results were statistically analysed using two-sample t-tests, assuming unequal variances. RESULTS: The individual mean IAE values on anterior and posterior tooth shapes with vertical and horizontal brushing were significantly (P < 0.001) higher for the toothbrush with extended bristles (Aquafresh Between Teeth) than for the other two toothbrush designs tested. When the data were combined to give an overall average, the IAE for the toothbrush with extended bristles (Aquafresh Between Teeth) was significantly (P < 0.001) higher than the IAE value for the toothbrushes containing x-angled (Oral-B CrossAction) or flat multitufted bristles (Oral-B Indicator). CONCLUSION: Based on the demonstrated predictability of the IAE assay for clinical interproximal plaque removal, the manual toothbrush with extended bristles should be an effective brush for cleansing the dental interproximal sites.

Use of two calcium concentrations in hemodialysis--report of a 20-year clinical experience.

Over the past almost 50 years several calcium concentrations in the dialysate (CaD) have been used to balance calcium in hemodialysis (HD) patients but a consensus as to which is most appropriate has not been established. Moreover, since the late 1980s, further confusion has been caused following the use of calcium salts as intestinal phosphate binders. This paper reports results of 387 chronic HD patients with respect to secondary hyperparathyroidism (sHPT) and renal osteodystrophy (ROD) of a single center over 20 years. The most important therapeutic measures applied were use of only 2 CaD, 1.5 and 1.75 mmol/l, with very few exceptions, administration of either calcium-containing or calcium-magnesium-containing and/or calcium-free phosphate binders, no dietary restrictions and continuous compensation of uremic acidosis via dialysate and oral supplements of bicarbonate. Using one of the two CaD and selective administration of different phosphate binders for fine adjustment of serum calcium through this combination, we were able to maintain in the long term almost physiological conditions. With exception of the phosphate metabolism, most physiological functions with regard to sHPT and ROD returned close to normal. As a result, the incidence of hypercalcemia, hypocalcemia, extraosseous, extravascular calcification, bone pain and spontaneous bone fractures was extremely low. We conclude that the clinical advantages of the therapeutic measures, above all precise balance of calcium homeostasis, in our investigation were demonstrated by high survival rates (92% after the first year on HD, 82% after 2, and 55% after 5 years), low incidence of cardiovascular fatalities (about 25%), and very low incidence of sHPT (mostly normal parathyroid hormone levels, 1 parathyrdoidectomy within 20 years).

Effect of feeding T-2 toxin contaminated feed on the utilisation of vitamin E in chickens.

The purpose of the present study was to investigate the effect of experimental T-2 toxin load (2.35 mg/kg of feed) and vitamin E supply in the drinking water (10.5 mg/bird/day) on vitamin E levels of the blood plasma and liver in broiler chickens in a 14-day experiment. It was found that T-2 toxin load did not influence vitamin E content of the blood plasma except at day 3 after the toxin load when a moderate increase was detected in plasma vitamin E. No significant changes were found in vitamin E content of the liver. The simultaneous use of high-dose vitamin E supplementation and T-2 toxin load caused a significantly higher plasma vitamin E content but the changes were less expressed in the group subjected to T-2 toxin load. Vitamin E supply also resulted in a marked and significant increase in vitamin E concentrations of the liver on days 3 and 7 even in the T-2 loaded group, but this concentration significantly decreased thereafter. The results show that T-2 contamination of the diet has an adverse effect on the utilisation of vitamin E in broiler chickens.

Sodium modeling.

The most serious side effects induced by hemodialysis therapy are caused by changes in sodium concentration and subsequent water shift between the intracellular and extracellular fluid compartment. Because of inadequate precision of proportioning, a certain sodium concentration and considerable error in the measurement of sodium concentration in dialysis fluid and plasma water, an error of up to 10 g in the diffusive exchange of sodium chloride remains in most dialysis sessions. Common side effects occur within this sodium balance error. Sodium modeling is a simplified mathematical method to describe quantitatively the fluid exchange in the body caused by changes in extracellular sodium concentration. It is based on fundamental physiologic properties of sodium and its permeability through the corresponding membranes. It also explains the different working mechanisms of sodium- and urea-related changes in osmolarity. Sodium modeling is a helpful tool for the illustration of the effects of changes in sodium concentration and ultrafiltration rate on sodium balance during one dialysis session. Sodium profiling is a method employed to avoid unwanted side effects of hemodialysis therapy by deliberately changing the sodium concentration in dialysis fluid during the course of a dialysis session. Clinical reports on practicing sodium profiling are unsatisfactory, involving only short trial periods in most cases. Most of the studies reported positive sodium balance with temporary decreases in intradialytic hypotension and less blood volume reduction, but with increases in thirst and body weight. To date, no validated studies with suitable control of sodium balance have been published that clearly demonstrate the long-term benefits of this mode of therapy compared with the use of constant dialysate sodium concentrations.

Sodium and body fluid homeostasis in profiling hemodialysis treatment.

Acute adverse side-effects of hemodialysis such as hypotension, muscle cramps, osmotic imbalance and thirst are induced by the interference with fluid and electrolyte balance occurring during treatment. Changes in osmolarity due to alterations of plasma sodium concentration during hemodialysis strongly influence fluid distribution between extracellular and intracellular fluid volume. Increased sodium dialysate concentration induces fluid shift from the intracellular to the extracellular compartment. This shift leads to a more efficient ultrafiltration by increasing plasma refilling volume but also to an increased thirst. Treatment of hypotension, cramps and nausea with hypertonic saline solution leads also to a considerable retention of sodium. Profiling hemodialysis consists in deliberately changing ultrafiltration and dialysate. sodium in order to combine an efficient ultrafiltration with a balanced sodium handling and to prevent side-effects during treatment. Continuous measurement and control of blood volume seems to be the best method to prevent hypotensive episodes. Profiling of sodium should not be the cause of a positive sodium balance. The clinical benefits of sodium profiling to the patients have still to be proven.

Short time dialysis with continuous blood volume control.

Continuous measurement of haemoglobin concentration is used to control changes of blood volume during haemodialysis. Ultrafiltration is either kept constant throughout the session or after starting with a rate (1.5 to 2 l/h), is manually controlled in order to limit blood volume reduction to a pre-set percentage. Ultrafiltration is step-wise decreased (a) or switched on and off (b) accordingly. Blood volume decrease with constant ultrafiltration is compared with method (a) and (b) in 4 stable haemodialysis patients. Constant ultrafiltration rate and the same total amount of ultrafiltrate causes a nearly 3% (mean) greater volume reduction as compared with method (a) and (b). No difference was observed in blood pressure and heart rate. We conclude that ultrafiltration in stable haemodialysis patients can be completed in short time without consequences for cardiovascular stability.

Diacap alpha-polysulfone HI PS: a new dialysis membrane with optimum beta2-microglobulin elimination.

BACKGROUND: Plasma concentration of beta2-microglobulin (beta2-m) in the case of renal insufficiency is about 20 to 30 times higher than normal. Beta2-m is associated with secondary amyloidosis, a late complication of regular dialysis therapy. To prevent the complications of secondary amyloidosis beta2-m should therefore be eliminated as efficiently as possible during dialysis treatment. This can be accomplished with dialysis membranes which guarantee sufficient clearance for this molecule. It is a matter of discussion whether removal of beta2-m by dialysis may be able to prevent secondary amyloidosis. METHODS: The dialyzers Diacap HI PS 15 (B. Braun Melsungen) and F70 S (Fresenius Medical Care) were compared in five anuric dialysis patients. Arterial blood was taken at the start and at the end of dialysis. Dialysate samples were taken after 30 and 210 minutes and filtrate samples after 60 and 240 minutes from the start of dialysis. Beta2-m and total protein concentration were measured in plasma, filtrate and dialysate. SDS-PAGE of proteins in the filtrate was carried out and kinetics of beta2-m (Kt/V(beta2-m)) were calculated using the Stiller/Mann model. RESULTS: In both dialyzers beta2-m is detectable at any time in the dialysate leaving the dialyzer. In the filtrate beta2-m concentration is about 10 times higher than in the dialysate. Protein pattern in filtrate of both dialyzers is similar and corresponds to that of the glomerulum filtrate. Beta2-m reduction ratio is slightly lower than urea reduction ratio. Using both dialyzers Kt/V(beta2-m) was 0.80, removing about 60% of the generated beta2-m. CONCLUSIONS: In both dialyzers there is considerable removal of beta2-m. Examination of beta2-m kinetics showed an optimum of Kt/V(beta2) of 0.80 which can not be surpassed. Only 60% of generated beta2-m can be removed by three times per week hemodialysis therapy using high-flux dialyzers.

Validation of a two-pool model for the kinetics of beta2-microglobulin.

UNLABELLED: Secondary amyloidosis due to beta-2-microglobulin (beta2-m) is a serious long-term complication in patients on regular dialysis therapy. Beta2-m can be considered a middle-molecule marker used to facilitate the assessment of dialysis efficacy. For this purpose, a validated model that calculates characteristic efficacy parameters, such as Kt/V, TAC and generation rate, is needed. There is general agreement that beta2-m-kinetics should be described by a two-pool model, but little has been published to validate such an approach. We measured the beta2-m concentration profiles of eight stable patients during hemodialysis (HD) at the start of treatment, after 30 minutes, after 60 minutes, and every hour until the end. Thereafter they were measured at 10-minute intervals for an hour. The dialyser clearances were determined from the plasma concentrations in front of and behind the dialyser twice during each session - after 1 hour, and 4 hours from the start of treatment. The kinetic parameters of a two-pool model (e.g. the compartment volumes V1 and V2, the mass transfer coefficient K12 and the generation rate G) were determined from the optimal fit of the measured concentration profile. The table below summarises the results by giving the mean and standard deviation for each parameter: [table: see text]. Inter-individual differences in V1/V2 and K12 were high, ranging from 2.5 to 10.0 for V/V2 and from 26 to 140 for K12. Error analysis suggested that these wide ranges were due to the method and that in reality the probable range of V is 25-36% of TBW, of V1/V2 3.5-5.3, and of K12 30-80 ml/min. With standard values for these three parameters (V = 30% of TBW, V/V2 = 4.4 and K12 = 55 ml/m), equal for all patients, and their respective ranges, Kt/W can be calculated with a standard deviation of 13%. Kt/W > 1.2 secures the maximum possible beta2-m removal with three HD treatments a week. CONCLUSIONS: The parameters of a two-pool model of beta2-m kinetics can be derived from concentration profiles obtained under routine dialysis conditions, but accuracy is not completely satisfactory. Similar to the dialysis dose for urea (Kt/Vurea) the dialysis dose for beta2-m (Kt/Vbeta2-m) can be calculated from the pre- and post-dialysis concentrations of beta2-m, body weight, ultrafiltration and dialysis time. Kt/Vbeta2-m > 1.2 secures the maximum possible removal of beta2-m in HD with three sessions per week.

Testing protein permeability of dialysis membranes using SDS-PAGE.

BACKGROUND: Permeability of dialysis membranes for high molecular weight compounds should be similar to that of the glomerular membrane in order to remove uremic toxins like the human kidney does. In order to evaluate permeability of high-flux dialysis membranes SDS-PAGE is applied for examination of filtrate of dialysers during routine dialysis with different membranes. METHOD: SDS-PAGE analysis is performed with silver staining method according to the modification of Melzer (5) and consecutive laser densitometry. RESULTS: The protein pattern of filtrate from dialysis membranes is similar to that of the glomerular membrane containing IgG, transferrin, albumin, alpha-1-microglobulin, retinol binding protein and beta-2-microglobulin. Comparing different membranes there are considerable differences depending on cut-off, charge and adsorption capacity of the particular membrane. In all membranes tested permeability of proteins decreases during one treatment session. CONCLUSION: Protein permeability of high-flux dialysis membranes is similar to the gloemerular membrane but modified according to pore-size, surface charge, adsorption and time on dialysis. In contrast to the glomerular membrane in each of the investigated membranes protein permeability decreases during function.

Kt/V a measure for quality control of haemodialysis therapy: how valid is it?

Since the beginning of maintenance haemodialysis many attempts have been made to quantify this kind of renal replacement therapy. The most widely used methods are urea kinetic models and simple approximation formulae based on measured data of the individual patients. The most common term of dialysis dose is Kt/V. The errors of data put into the calculations are transferred to the result. Analysis of the error of the calculated result depending on the errors of the primary data using Gauss' law of progression of errors reveals errors of the calculated Kt/V between 7.7% and 18%. It is concluded that comparison of different groups of dialysis patients by means of Kt/V should only be done using one method with the least error.

The Donnan effect in artificial kidney therapy.

The calculation of the effective sodium gradient in dialysis has to consider a membrane potential difference which is generally derived from the Donnan effect. Strictly this is allowed only under equilibrium conditions. This paper considered the effect of the deviation from equilibrium in haemodialysis and haemofiltration. The mathematical analysis is based on the integration of the local transport rate over the membrane area. The local transport rate is calculated from the Nernst-Planck equation using the constant field assumption. Deviation from equilibrium results in a diffusion potential across the membrane. Experimental evidence was presented for part of the theoretical results. The diffusion potential, both in haemodialysis and in haemofiltration, is too small to have any clinical significance. From the theory it follows that better tolerance of haemofiltration in comparison with haemodialysis cannot be explained by a difference in sodium transport. Calculation of the sodium transport in dialysis therapy based on the equilibrium Donnan effect is sufficiently accurate for kinetic considerations in the dialysis routine.

Ionometry versus flame photometry in dialysis therapy.

In order to decide whether the ionometer can be accepted as an alternative to the flame photometer in the measurement of sodium and potassium, extensive measurements with ionometry in parallel with flame photometry were performed in serum and dialysis fluid during dialysis. The influence of parameters which influence both ionometry and flame photometry in a different way (protein concentration, pH, acetate, and bicarbonate concentration) was investigated. The correlation between the two methods for potassium in serum and dialysis fluid was excellent (r greater than 0.95), but unsatisfactory for sodium in serum (r = 0.77) and in dialysis fluid (r less than 0.85). This low correlation is attributed in a greater extent to the random errors caused by flame photometry than by ionometry. Ionometry can be accepted as an alternative to flame photometry in dialysis therapy.

A new method of continuous haemoglobinometric measurement of blood volume during haemodialysis.

Since the total amount of haemoglobin in blood is constant during haemodialysis, haemoglobin concentration reflects changes of blood volume caused by ultrafiltration and solute transport. Haemoglobin concentration therefore could serve as a control parameter for ultrafiltration. Blood is taken continuously from the arterial blood line at the very small rate of 0.1 ml/h and diluted at a constant ratio of 1/200 by a sterile solution 0.05 per cent NH3. By the diluting medium the erythrocytes are haemolysed and the haemoglobin is transformed into oxyhaemoglobin. The haemoglobin concentration is determined measuring the absorbance at 415 nm. The error in the measurement of the haemoglobin concentration is less than 3 per cent. The method was tested in vivo during 10 haemodialysis treatments of five patients. Haemoglobin concentration appeared to reflect the well-known effects of ultrafiltration, of food intake and changes of position (sitting, lying). If the body weight approached the suspected dry weight, haemoglobin concentration increased more rapidly. During high ultrafiltration rates (1.0 litre/h) and sudden changes of ultrafiltration rate haemoglobin concentration seemed to be unevenly distributed in the vascular space. If haemoglobin concentration indeed reflects changes in blood volume the method can be used to study the relationship between blood volume and blood pressure in haemodialysis therapy and to control ultrafiltration.

Biological balance of sodium and potassium: a control system with oscillating correcting variable.

The rhythm of renal sodium and potassium excretion was measured in 4-h-intervals in 12 subjects. Each person exhibited clear circadian variations of each variable with a maximum between 8 a.m. and 4 p.m. In each subject and for both circadian rhythms the oscillation mean was correlated to the range of oscillation (amplitude). Increase in sodium or potassium excretion during 1 day resulted in an increase of oscillation range. The oscillation means of sodium and potassium periodicity did not correlate. The properties of biological control systems with oscillating correcting variables are comparable to those of technical control systems. The significance of circadian rhythm for the control of electrolyte balance is indicated.

Theoretical aspects of various ultrafiltration methods in artificial kidney therapy.

A mathematical model including urea, creatinine and other osmotically important solutes (such as sodium, potassium and chloride) is applied to calculate volume shifts, caused by ultrafiltration, between the fluid compartments of the body. The volume shifts between the intracellular (ICV) and the extracellular (ECV) compartments are mainly caused by alteration of extracellular sodium concentration. Various methods of achieving ultrafiltration, including conventional dialysis, initial ultrafiltration using Cuprophan (without dialysis) or hemofiltration, produce different responses. In choosing a method, one must consider that both a rapid decrease of ECV and a fast shift of water from ICV to ECV should be avoided. In pure hemofiltration, ultrafiltrate is isotonic and water is removed from ECV only. Hemofiltration with dilution produces a very slow shift of water between ICV and ECV dependent on sodium concentration of plasma and diluting fluid. In initial ultrafiltration through Cuprophan, water is shifted from ICV to ECV. With ultrafiltration throughout the entire dialysis, there are pronounced shifts between ICV and ECV dependent on the difference of the sodium concentration between plasma and dialysate.

Kinetic modelling and continuous on-line blood volume measurement during dialysis therapy.

Changes of relative blood volume during haemodialysis therapy have been investigated using kinetic modelling and on-line blood volume registration by continuous haemoglobinometry. An exponential relation has been found between blood volume reduction per litre of ultrafiltrate and the amount of fluid overload. Between the amount of refilling and ultrafiltration rate there was also an exponential dependence. There was a linear relation between the change in plasma sodium concentration and blood volume. An acceptable correspondence was found between calculated and measured data.

On-line Urea Monitoring during Hemodialysis: A Review.

In recent years, methods of on-line urea concentration and on-line urea clearance monitoring have been proposed for control of dialysis dose (Kt/V) and protein catabolic rate (PCR) in patients on regular dialysis therapy; these offer an alternative to the established methods of urea kinetics based on pre- and post-dialysis measurements of urea concentration. In contrast to such conventional urea kinetics, the new methods deliver results in real time and treatment parameters can be changed instantly. Three on-line measurement methods are to be distinguished: monitoring of urea concentration in ultrafiltrate, monitoring of urea concentration in dialysate (both yield Kt/V and PCR), and monitoring of urea clearance based on conductivity measurements. Some of these approaches are already applied commercially. Here, these methods are compared using results obtained from laboratory and clinical studies. The on-line methods are found to be more accurate than methods based on pre- and post-dialysis urea concentrations, and to be better suited for clinical routine. This paper outlines the principal methods, reviews the present literature, gives an overview of the applications and compares them to conventional pre- and post-dialysis concentration-based methods of urea kinetics. It is concluded that these methods are likely to find a widespread application in the control of dialysis adequacy.

Changes in blood volume during dialysis are dependent upon the rate and amount of ultrafiltrate.

Actual circulating blood volume during dialysis therapy can be monitored by continuous hemoglobinometry. Using this method in 15 stable, clinically nonoverhydrated dialysis patients, blood volume was recorded applying different modes of ultrafiltration: constant ultrafiltration (less than 500 ml/hr); high initial (greater than 1,500-2,000 ml/hr), subsequently decreasing ultrafiltration; and intermittently high (greater than 1,500 ml/hr) ultrafiltration. Mean amount of ultrafiltrate in all patients was 3,400 ml. Mean decrease in blood volume by 20% was generally tolerated without a decrease in blood pressure. Irrespective of the different modes of ultrafiltration, a decrease in blood volume was dependent only on the amount of ultrafiltered fluid. A constant, low ultrafiltration rate was not superior to a high ultrafiltration rate. In stable dialysis patients, decrease in blood volume is dependent only on the amount of ultrafiltrate. Up to a 20% decrease in blood volume, fluid can be removed from the patient even at a rate of 2,000 ml/hr.